Don't get left out at sea! Prepare now for ASH-a-Palooza at #ASH25🐬 ◽Sign up early for Blood Buddy speed mentoring: https://ow.ly/Cafw50XA6Gt ◽Arrive by 11:45 a.m. for the Global Hematology Trainee Networking Lunch ◽Join the AAP treasure hunt ( in the #ASH25 app) #ASHTrainee ASH Education

The #ASH25 virtual platform is now live! Log in now using the ASH username and password you used to register for the annual meeting: https://ow.ly/MmlR50XBiMT#ASH25 🌟Your bonus and preview content await. Plus, explore networking, exhibits, and more on the virtual platform! #HemeSky #MedSky

Your go-to social media guide for #ASH25 is here. Find tips on following updates, taking part in conversations, using the official hashtags, and entering fun challenges with #ASHNewsDaily. Read now: https://ow.ly/tEgJ50XxAP6#ASH25#ASHNewsDaily #HemeSky #ASHaiku #ASHKudos #ASHRunWalk #ASHScavengerHunt

The ASH annual meeting is the premier venue for #hematology collaborations across borders 🌏 #ASHThrowback to a meeting with ASH and the Mediterranean Partner Societies at #ASH24. Belinda Avalos, MD#hematology#ASHThrowback#ASH24#ASH25 International community, share your throwbacks from past ASH meetings! #HemeSky

Finally in Boston! Honored to join @danafarber.bsky.social, eager to learn and contribute in this terrific community @coleman-lindsley.bsky.social. A place of science, purpose and hope.

Thank you all who made COSTEM 2025 THE event for transplant & cellular therapies❗️ Faculty who fight REAL debates Audience that ask REAL questions Unity amid controversy🙏 See you 1-3 October 2026 in Berlin again!

Last Call for Early Bird Registration Join us at the 10th COSTEM Congress! 🗓️ September 25–28, 2025 📍 Berlin, Germany Don't miss your chance to save – Early Bird registration closes July 31st! costem.cme-congresses.com/registration/

🎥 Check out our recent interview from #CART25 with @nicogagelmann.bsky.social, in which he highlights the need to address inequality & inequity in access to #CARTCell therapy across Europe: 👉 buff.ly/4gBhWeD #ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky

Out now in Blood Advances 🙌🏽 Our work from Princess Margaret Cancer Centre evaluating the role of PTCy in matched sibling donor allogeneic transplantation! Also read this excellent commentary by my good friend @nicogagelmann.bsky.social 👇🏽 ashpublications.org/bloodadvance...

MAKE CAR-T AFFORDABLE AGAIN Terrific learning experience from cellular therapy programs in India, Slovenia, Brazil and Turkey #CART25

Let's learn hematology in 2025🩸 Day 27: hemophilia characteristics

🎉Finally published🎉 Cilta-cel vs ide-cel for relapsed or refractory multiple myeloma @hemasphere-journal.bsky.social onlinelibrary.wiley.com/doi/full/10....

🎉Finally published🎉 Clearance of driver mutations after transplantation for myelofibrosis @nejm.org www.nejm.org/doi/full/10....

In a single-group, single-center study, clearance of driver mutations 30 days after bone marrow transplantation predicted long-term disease-free survival in patients with myelofibrosis. Read the full study results: nej.md/4fQNdKn #MedSky

Talquetamab plus Teclistamab in Multiple Myeloma (RedirecTT-1 study) nej.md/4iZNYTY Driver Mutations in Myelofibrosis (single-group, single-center study) nej.md/4fQNdKn

a blockbuster paper by @nicogagelmann.bsky.social et al in @nejm.org on the impact of driver mutation clearance in patients with MF that underwent allo-HCT! www.nejm.org/doi/full/10....

🎉Finally published🎉 Clearance of driver mutations after transplantation for myelofibrosis @nejm.org www.nejm.org/doi/full/10....

#ASHKudos for the award. Glad that you had fun at #ASH24!

What a wonderful #ASH24 Honored to receive @ash-hematology.bsky.social Abstract Achievement Award, meet friends, celebrate colleagues' achievements, enjoy terrific science and San Diego. Until next year 🙏🩸❤️

Tomorrow @nicogagelmann.bsky.social will take over our Twitter account, bringing you live updates & expert takes straight from #ASH24 🗞️🩸📱 Give us a follow over there so you don't miss the action 👉 x.com/VJHemOnc 👀

Now @nicogagelmann.bsky.social on molecular genetics and JAKi impact on allo-HCT in MF -1800 rux treated pts -early allo in high-risk PMF and SMF seems to be best timing -early allo in TP53 may offer survival benefit

🎉Finally out and timely for #ASH24 @ash-hematology.bsky.social 🎉 Happy to share our international work suggesting bispecific antibodies as standard of care for relapse after CAR-T in multiple #myeloma #mmsm t.co/F7QjOoavKO

Happy to present first European comparison of cilta-cel vs ide-cel for #myeloma #ASH24: -Cilta-cel with better ORR, CR, PFS -Similar NRM -Peak CAR-T expansion day 14 for cilta-cel vs day 7 for ide-cel 👉associated with response and with ICANS for cilta-cel @ash-hematology.bsky.social

Honored to be featured on the @ash-hematology.bsky.social ASH News Daily #ASH24 follow list! I'll be posting on both my Twitter (https://buff.ly/3Zy7BLc) and BS (https://buff.ly/3B9SpKU), so please do follow! https://buff.ly/49iWb1d

cc @rahulbanerjeemd.bsky.social @shematologist.bsky.social @nicogagelmann.bsky.social

#ASH24 of the day: Talquetamab Bridging before CAR-T -Talq bridging: 62% ORR (14% CR) -Post-CAR-T: 97.5% ORR (35% CR) -Safety: Mild toxicities during talq (no grade ≥3 CRS, 2.5% ICANS) -Post-CAR-T: less CRS (65%), ICANS (2% grade 3) Should be standard of care #mmsm @ash-hematology.bsky.social

🌟 Attention trainees! ASH-a-Palooza is just one week away! There’s still time to register for this trainee-focused party full of beats, free bites, & burst of learning. Kicking off #ASH24 next Friday! Register: bit.ly/ASH-a-Palooza #ASHTrainee #HemeSky #Hematology #Fellow #MedSky #HemeOnc

That escalated quickly

This platform is also the place to share and circulate: Donate blood🙏🩸 Donate stem cells🙏🩸 It doesnt hurt and save lives. Be a hero, in the real world. Be a hero here, and spread the word. #donate #medsky #bmtsm

Science and medicine should NEVER EVER mix with politics🙏

20 people work for @bsky.app in Seattle. These 20 people ensure freedom of communication🤣🤣

The world needs resonance, not following not likes. Real engagement is what makes the world a better place and helps you find real friends.

Elon with Twitter! @nicogagelmann.bsky.social @drneilstone.bsky.social

Why did the platelet bring a date to the clot? Because it didn’t want to stick around alone!

I have a meropenem joke but I won't let you use it

Follow me on #Bluesky because the future deserves your good taste in people🤣

I was going to tell you a chemistry joke, but I didn’t think it would get a reaction.

Hello, #hematology community! ASH is now on BlueSky. We're here to share cutting-edge research and educational resources and connect global experts in blood diseases. Join us in advancing hematology together. Welcome, colleagues! #BloodSky #HemeSky #MedSky

Bluesky is the new destination for X/Twitter’s health and science community. Here’s why #MedSky #ScienceSky 🥼🧪https://www.statnews.com/2024/11/21/bluesky-gains-twitter-exodus-science-medical-community-finds-alternative-to-x/

🎉📢 Delighted to share our work from Princess Margaret Cancer Centre 🙌🏼 PTCy-based GvHD prophylaxis was associated with an improved GRFS, NRM, and OS 💪🏼 A big shout-out to @haemophage.bsky.social for his mentorship 🙌🏼 doi.org/10.1182/bloo... #MedSky #HemeSky

Imagine that...

Donate blood and stem cells🙏 It doesnt hurt and you save a life. Register now @dkms-de.bsky.social or others🩸

The reason why we are here

Every single day I’m on service, no matter how tough it is, I remind myself that I get to go home and my babies are there and we all have our health and aren’t staying the night in the hospital. Perspective is everything.

First rule of academia: God is called "The Deadline"

Finally out🎉 Role of molecular alterations in transplant decision for primary myelofibrosis Wonderful international collaboration #medskey ashpublications.org/bloodadvance...

Invest in the future, not the present, not the past!